Narayana Hrudayalaya Limited (NSE:NH)

Market Cap	379.63B +4.9%
Revenue (ttm)	90.72B +59.6%
Net Income	8.16B +3.9%
EPS	40.19 +3.9%
Shares Out	203.10M
PE Ratio	46.22
Forward PE	31.93
Dividend	4.50 (0.23%)
Ex-Dividend Date	Jul 17, 2026

Volume	183,485
Open	1,903.00
Previous Close	1,909.70
Day's Range	1,864.60 - 1,908.30
52-Week Range	1,589.00 - 2,093.30
Beta	0.14
Analysts	Buy
Price Target	2,213.07 (+18.35%)
Earnings Date	Nov 13, 2026

About Narayana Hrudayalaya

Narayana Hrudayalaya Limited provides medical and healthcare services in India, the United Kingdom, and the Cayman Islands. It operates through the Medical and Healthcare Related Services; and Others segments. The company offers oncology, anesthesiology, audiology, blood bank, breast oncology, oncoplastic surgery, cardiac surgery, cardiology, clinical genetics, clinical immunology, clinical nutrition and dietetics, clinical psychology, congenital adult heart disease, cosmetology, cranio-maxillofacial surgery, critical care medicine, dental, der...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 2000
• Employees: 11,234
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: NH

Financial Performance

In fiscal year 2026, Narayana Hrudayalaya's revenue was 78.96 billion, an increase of 44.01% compared to the previous year's 54.83 billion. Earnings were 8.06 billion, an increase of 1.95%.

Analyst Summary

According to 14 analysts, the average rating for NH stock is "Buy." The 12-month stock price target is ₹2,213, which is an increase of 18.35% from the latest price.

Price Target

₹2,213

(18.35% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 11, 2026

Data Sources Report a data error